Africa Must Lead HIV Cure Research or Repeat Past Delays, Experts Warn
Albert Machinda of the Africa HIV Cure Consortium has urged African nations to lead HIV cure research to avoid historical delays in accessing medical innovations. He noted that Africa carries the highest HIV burden but contributes minimally to global cure research.
Why it matters
It addresses the systemic inequality in global medical research and the need for regional self-sufficiency in public health.
Africa must take charge of HIV cure research or risk repeating past delays in accessing lifesaving medical innovations, the head of the Africa HIV Cure Consortium, Albert Machinda, has warned.
Machinda, who is the consortium's Principal Investigator and head of Secretariat, made the remarks during the 2026 HIV Research Community Symposium in Kampala, where he urged African governments, researchers and communities to lead the next phase of HIV science.
He said Africa's historical dependence on medical breakthroughs developed outside the continent had delayed access to HIV treatment, pre-exposure prophylaxis (PrEP) and COVID-19 vaccines, costing many lives.
"If we look at the history of HIV and where we've come from, we do not want to be left behind," Machinda said, arguing that Africa has largely remained a consumer rather than a producer of medical innovations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in